This inventor holds 1 USPTO granted patent and 9 published patent applications, plus 1 CIPO patent. Top assignee: Ensol Biosciences Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Young Hoon Lee: Innovator in Peptide Research
Introduction
Young Hoon Lee is a prominent inventor based in Sejong, South Korea. He has made significant contributions to the field of peptide research, particularly in the context of treating autoimmune diseases. His innovative work has the potential to impact the lives of many individuals suffering from type 1 diabetes.
Latest Patents
Young Hoon Lee holds a patent for a peptide that consists of the amino acid sequence of SEQ ID NO:1 or a pharmaceutically acceptable salt thereof. This invention is capable of effectively treating or preventing insulitis and type 1 diabetes. The implications of this research are profound, as it addresses critical health issues related to autoimmune responses.
Career Highlights
Lee is associated with Ensol Biosciences Inc., where he continues to advance his research in peptide applications. His work is characterized by a commitment to developing therapeutic solutions that can improve patient outcomes in the realm of diabetes care.
Collaborations
Some of his notable coworkers include Hae Jin Kim and Eun-Joung Moon, who contribute to the collaborative efforts at Ensol Biosciences Inc. Their combined expertise enhances the research environment and fosters innovation.
Conclusion
Young Hoon Lee's contributions to peptide research exemplify the potential of innovative solutions in medicine. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile